Activity of the 5-HT1A receptor is involved in the alteration of glucocorticoid receptor in hippocampus and corticotropin-releasing factor in hypothalamus in SPS rats

被引:53
|
作者
Wang, Hai-Tao [1 ]
Han, Fang [1 ]
Shi, Yu-Xiu [1 ]
机构
[1] China Med Univ, Basic Med Sci Coll, Dept Histol & Embryol, Shenyang 110001, Liaoning, Peoples R China
基金
中国国家自然科学基金;
关键词
serotonin type 1A receptor; single-prolonged stress; glucocorticoid receptor; corticotropin-releasing factor; post-traumatic stress disorder; SINGLE-PROLONGED STRESS; DEXAMETHASONE; EXPRESSION; DEPRESSION; RELEVANCE; FEEDBACK; MODEL; ACTH;
D O I
10.3892/ijmm_00000225
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Rats exposed to single-prolonged stress (SPS) showed enhanced inhibition of the hypothalamic-pituitary-adrenal (HPA) system and alteration in the glucocorticoid/mineralocorticoid receptor. Dysfuntion of the HPA axis is one of the core neuroendocrine abnormalities of post-traumatic stress disorder (PTSD). Serotonergic receptor, glucocorticoid receptor (GR) and corticotropin-releasing factor (CRF) have been proposed to play major roles in dysfuntion of the HPA axis. However, the precise molecular mechanism is unknown. In this study, we investigated the relationships between the changes of GR in hippocampus as well as CRF in hypothalamus and the activity of 5-HT1A receptor in SPS rats. We exposed rats to SPS with or without prior treatment with WAY100635 (the 5-HT1A receptor antagonist), and observed behavioral changes, GR levels in the hippocampus and CRF levels in the hypothalamus by immunohistochemistry, Western blotting and RT-PCR seven days after SPS. Our results demonstrate that SPS increases expression of GR and CRF, which were partially inhibited by WAY100635.
引用
收藏
页码:227 / 231
页数:5
相关论文
共 50 条
  • [1] A sexually dimorphic distribution of corticotropin-releasing factor receptor 1 in the paraventricular hypothalamus
    Rosinger, Zachary J.
    Jacobskind, Jason S.
    De Guzman, Rose M.
    Justice, Nicholas J.
    Zuloaga, Damian G.
    NEUROSCIENCE, 2019, 409 : 195 - 203
  • [2] Effect of Glucocorticoid Receptor Blockade on Analgesic Effect of Corticotropin-Releasing Factor
    Yarushkina, N. I.
    Bagaeva, T. R.
    Filaretova, L. P.
    BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE, 2011, 150 (05) : 579 - 582
  • [3] Effect of Glucocorticoid Receptor Blockade on Analgesic Effect of Corticotropin-Releasing Factor
    N. I. Yarushkina
    T. R. Bagaeva
    L. P. Filaretova
    Bulletin of Experimental Biology and Medicine, 2011, 150 : 579 - 582
  • [4] Corticotropin-releasing factor 1 receptor antagonists: a patent review
    Williams, John P.
    EXPERT OPINION ON THERAPEUTIC PATENTS, 2013, 23 (08) : 1057 - 1068
  • [5] Toxicity of Pexacerfont, a Corticotropin-Releasing Factor Type 1 Receptor Antagonist, in Rats and Dogs
    White, Melvin R.
    Graziano, Michael J.
    Sanderson, Thomas P.
    INTERNATIONAL JOURNAL OF TOXICOLOGY, 2019, 38 (02) : 110 - 120
  • [6] Corticotropin-releasing factor 1 receptor-mediated mechanisms inhibit colonic hypersensitivity in rats
    Greenwood-van Meerveld, B
    Johnson, AC
    Cochrane, S
    Schulkin, J
    Myers, DA
    NEUROGASTROENTEROLOGY AND MOTILITY, 2005, 17 (03) : 415 - 422
  • [7] Intermale aggression in corticotropin-releasing factor receptor 1 deficient mice
    Gammie, SC
    Stevenson, SA
    BEHAVIOURAL BRAIN RESEARCH, 2006, 171 (01) : 63 - 69
  • [8] Alterations in corticotropin-releasing factor receptor type 1 in the preoptic area and hypothalamus in mice during the postpartum period
    De Guzman, Rose M.
    Rosinger, Zachary J.
    Parra, Katherine E.
    Jacobskind, Jason S.
    Justice, Nicholas J.
    Zuloaga, Damian G.
    HORMONES AND BEHAVIOR, 2021, 135
  • [9] Corticotropin-Releasing Factor Receptor 1 Antagonism Is Ineffective for Women With Posttraumatic Stress Disorder
    Dunlop, Boadie W.
    Binder, Elisabeth B.
    Iosifescu, Dan
    Mathew, Sanjay J.
    Neylan, Thomas C.
    Pape, Julius C.
    Carrillo-Roa, Tania
    Green, Charles
    Kinkead, Becky
    Grigoriadis, Dimitri
    Rothbaum, Barbara O.
    Nemeroff, Charles B.
    Mayberg, Helen S.
    BIOLOGICAL PSYCHIATRY, 2017, 82 (12) : 866 - 874
  • [10] Effects of triiodothyronine on 5-HT1A and 5-HT1B autoreceptor activity, and postsynaptic 5-HT1A receptor activity, in rat hypothalamus:: lack of interaction with imipramine
    Gur, E
    Lifschytz, T
    Van de Kar, LD
    Lerer, B
    Newman, ME
    PSYCHONEUROENDOCRINOLOGY, 2004, 29 (09) : 1172 - 1183